Medtronic launches Prevail DCB following CE mark | 合法醫療器材資訊網

2021年7月27日—MedtronichaslaunchedthePrevaildrugcoatedballoon(DCB)CatheterinEuropefollowingCEmark.ThePrevailDCBisusedduring ...

Medtronic has launched the Prevail drug coated balloon (DCB) Catheter in Europe following CE mark. The Prevail DCB is used during percutaneous coronary intervention (PCI) procedures to treat narrowed or blocked coronary arteries in patients with coronary artery disease (CAD).

During the catheter-based procedure, the balloon inflates within the artery, while the drug is delivered to the arterial tissue where it is absorbed. The Prevail DCB utilises a rapid absorption drug – paclitaxel – to enable treatment of de novo lesions, small vessel disease, and in-stent restenosis (ISR). DCB angioplasty does not require a permanent implant and is often used in cases where the implantation of a drug-eluting stent (DES) is not desirable or is technically challenging.

Azeem Latib, M.D., lead principal investigator of the PREVAIL Study and se...